Calix Past Earnings Performance
Past criteria checks 0/6
Calix's earnings have been declining at an average annual rate of -33.2%, while the Chemicals industry saw earnings growing at 6.6% annually. Revenues have been growing at an average rate of 24.2% per year.
Key information
-33.2%
Earnings growth rate
-24.9%
EPS growth rate
Chemicals Industry Growth | 14.4% |
Revenue growth rate | 24.2% |
Return on equity | -28.5% |
Net Margin | -120.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We're Keeping An Eye On Calix's (ASX:CXL) Cash Burn Rate
Apr 19Analyst Forecasts For Calix Limited (ASX:CXL) Are Surging Higher
Mar 02Calix (ASX:CXL) Is In A Good Position To Deliver On Growth Plans
Sep 26Calix Limited's (ASX:CXL) Business Is Yet to Catch Up With Its Share Price
Jul 01Analysts Just Shaved Their Calix Limited (ASX:CXL) Forecasts Dramatically
Aug 28Calculating The Intrinsic Value Of Calix Limited (ASX:CXL)
Jul 08The Calix (ASX:CXL) Share Price Is Up 87% And Shareholders Are Holding On
Feb 18An Intrinsic Calculation For Calix Limited (ASX:CXL) Suggests It's 25% Undervalued
Jan 14What Is The Ownership Structure Like For Calix Limited (ASX:CXL)?
Dec 10Revenue & Expenses BreakdownBeta
How Calix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 22 | -27 | 24 | 19 |
30 Sep 23 | 20 | -25 | 22 | 17 |
30 Jun 23 | 19 | -23 | 20 | 15 |
31 Mar 23 | 18 | -21 | 17 | 12 |
31 Dec 22 | 17 | -18 | 15 | 10 |
30 Sep 22 | 18 | -17 | 14 | 9 |
30 Jun 22 | 18 | -16 | 13 | 7 |
31 Mar 22 | 19 | -14 | 13 | 7 |
31 Dec 21 | 20 | -12 | 12 | 7 |
30 Sep 21 | 20 | -10 | 11 | 7 |
30 Jun 21 | 19 | -7 | 10 | 7 |
31 Mar 21 | 19 | -7 | 10 | 7 |
31 Dec 20 | 20 | -6 | 9 | 6 |
30 Sep 20 | 17 | -7 | 8 | 6 |
30 Jun 20 | 14 | -7 | 8 | 6 |
31 Mar 20 | 10 | -7 | 7 | 6 |
31 Dec 19 | 5 | -6 | 6 | 6 |
30 Sep 19 | 4 | -7 | 6 | 6 |
30 Jun 19 | 3 | -7 | 5 | 7 |
31 Mar 19 | 4 | -7 | 4 | 7 |
31 Dec 18 | 4 | -6 | 4 | 6 |
30 Sep 18 | 4 | -5 | 3 | 6 |
30 Jun 18 | 4 | -3 | 3 | 5 |
31 Mar 18 | 4 | -3 | 3 | 5 |
31 Dec 17 | 4 | -2 | 2 | 6 |
30 Sep 17 | 4 | -2 | 2 | 6 |
30 Jun 17 | 4 | -2 | 2 | 6 |
30 Jun 16 | 14 | -2 | 4 | 3 |
30 Jun 15 | 7 | -4 | 4 | 2 |
Quality Earnings: CXL is currently unprofitable.
Growing Profit Margin: CXL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CXL is unprofitable, and losses have increased over the past 5 years at a rate of 33.2% per year.
Accelerating Growth: Unable to compare CXL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CXL is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-53.6%).
Return on Equity
High ROE: CXL has a negative Return on Equity (-28.53%), as it is currently unprofitable.